The COMET trial is intended for patients with 1-5 brain metastasis from non-small cell lung cancer. This clinical trial is the first one evaluating the safety and efficacy of the NovoTTF-100M System for this indication. This System delivers Tumor Treating Fields (TTFields) to the cancer sites in the brain. Novocure Ltd., the trial sponsor, maintains this website to help patients get basic information about the clinical trial and facilitate their accessibility to medical centers that offer participation in the trial. If you would like to take part in the COMET trial, please contact one of the participating centers as soon as possible. If you have questions concerning your medical condition and recommended treatment, please consult with your treating doctor.